ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,572.07
      -0.76%
      US Tech 100
      18,922.80
      0.07%
      Dow Jones
      41,433.48
      -1.14%
      Brent Oil
      69.635
      -0.11%
      Bitcoin
      82,968.18
      0.14%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Palvella Therapeutics Inc (PVLA) Quote

      Palvella Therapeutics Inc

      Palvella Therapeutics Inc (PVLA)

      NASDAQ
      27.99
      2.83
      (11.25%)
      Closed March 11 4:00PM
      Delayed by 15 minutes
      27.99
      0.00
      (0.00%)
      After Hours: 7:00PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      27.99
      Bid
      26.41
      Ask
      29.06
      Volume
      132,166
      24.51 Day's Range 28.00
      11.10 52 Week Range 27.90
      Market Cap
      36.954M
      Previous Close
      25.16
      Open
      25.00
      Last Trade
      2
      @
      28.66
      Last Trade Time
      Financial Volume
      $ 3,537,819
      VWAP
      26.768
      Average Volume (3m)
      47,045
      Shares Outstanding
      1,320,240
      Dividend Yield
      -
      PE Ratio
      -0.51
      Earnings Per Share (EPS)
      -55
      Revenue
      7.98M
      Net Profit
      -72.62M

      About Palvella Therapeutics Inc

      Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of mol... Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343, and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm functions through the region of the United States. Show more

      Sector
      General Indl Mach & Eq, Nec
      Industry
      Blank Checks
      Website
      www.sarcos.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2021
      Palvella Therapeutics Inc is listed in the General Indl Mach & Eq sector of the NASDAQ with ticker PVLA. The last closing price for Palvella Therapeutics was $25.16. Over the last year, Palvella Therapeutics shares have traded in a share price range of $ 11.10 to $ 27.90.

      Palvella Therapeutics currently has 1,320,240 shares outstanding. The market capitalization of Palvella Therapeutics is $33.22 million. Palvella Therapeutics has a price to earnings ratio (PE ratio) of -0.51.

      Ask ADVFN Intelligence (AI)

      PVLA Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      March 04 2025
      PVLA (11.25%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      February 18 2025
      PVLA (11.25%)

      Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
      Edgar (US Regulatory)
      February 10 2025
      PVLA (11.25%)

      Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
      Edgar (US Regulatory)
      February 10 2025
      PVLA (11.25%)

      Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
      Edgar (US Regulatory)
      February 10 2025
      PVLA (11.25%)

      Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
      Edgar (US Regulatory)
      February 10 2025
      PVLA (11.25%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 07 2025
      PVLA (11.25%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      18.41542.988505747119.57527.919.137291623.69794596CS
      412.1476.593059936915.8527.914.685349320.79040955CS
      1214.99115.3076923081327.911.14704516.46107509CS
      2614.35105.20527859213.6427.911.14642116.44297751CS
      5214.35105.20527859213.6427.911.14642116.44297751CS
      15614.35105.20527859213.6427.911.14642116.44297751CS
      26014.35105.20527859213.6427.911.14642116.44297751CS

      PVLA - Frequently Asked Questions (FAQ)

      What is the current Palvella Therapeutics share price?
      The current share price of Palvella Therapeutics is $ 27.99
      How many Palvella Therapeutics shares are in issue?
      Palvella Therapeutics has 1,320,240 shares in issue
      What is the market cap of Palvella Therapeutics?
      The market capitalisation of Palvella Therapeutics is USD 33.22M
      What is the 1 year trading range for Palvella Therapeutics share price?
      Palvella Therapeutics has traded in the range of $ 11.10 to $ 27.90 during the past year
      What is the PE ratio of Palvella Therapeutics?
      The price to earnings ratio of Palvella Therapeutics is -0.51
      What is the cash to sales ratio of Palvella Therapeutics?
      The cash to sales ratio of Palvella Therapeutics is 4.62
      What is the reporting currency for Palvella Therapeutics?
      Palvella Therapeutics reports financial results in USD
      What is the latest annual turnover for Palvella Therapeutics?
      The latest annual turnover of Palvella Therapeutics is USD 7.98M
      What is the latest annual profit for Palvella Therapeutics?
      The latest annual profit of Palvella Therapeutics is USD -72.62M
      What is the registered address of Palvella Therapeutics?
      The registered address for Palvella Therapeutics is 108 W. 13TH STREET SUITE 100, WILMINGTON, DELAWARE, 19801
      What is the Palvella Therapeutics website address?
      The website address for Palvella Therapeutics is www.sarcos.com
      Which industry sector does Palvella Therapeutics operate in?
      Palvella Therapeutics operates in the BLANK CHECKS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RAYRaytech Holding Ltd
      $ 1.69
      (94.25%)
      		104.03M
      TSVT2seventy bio Inc
      $ 4.945
      (76.61%)
      		31.49M
      HSAIHesai Group
      $ 24.10
      (50.53%)
      		26.82M
      SPHLSpringview Holdings Ltd
      $ 6.00
      (47.06%)
      		1.63M
      SYRSSyros Pharmaceuticals Inc
      $ 0.1334
      (45.63%)
      		695.66M
      WCTWellchange Holdings Company Limited
      $ 0.68417
      (-72.74%)
      		37.72M
      ARVNArvinas Inc
      $ 8.29
      (-52.79%)
      		19.03M
      LZMHLZ Technology Holdings Ltd
      $ 8.011
      (-48.84%)
      		685.95k
      HTCOHigh Trend International Group
      $ 1.41
      (-33.80%)
      		188.46k
      SPGCSacks Parente Golf Inc
      $ 0.1061
      (-33.73%)
      		36.38M
      SYRSSyros Pharmaceuticals Inc
      $ 0.1334
      (45.63%)
      		695.66M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0402
      (20.00%)
      		411.84M
      NVDANVIDIA Corporation
      $ 108.76
      (1.66%)
      		354.43M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 7.93
      (7.45%)
      		304.67M
      CUTRCutera Inc
      $ 0.1079
      (-16.03%)
      		218.46M

      PVLA Discussion

      View Posts
      $oldier Hard $oldier Hard 2 days ago
      $PVLA, Scotia bank initiates coverage on PVLA with sector outperform rating price target $50.00.
      👍️0
      $oldier Hard $oldier Hard 6 days ago
      $PVLA, analyst price target $39.00
      👍️0
      $oldier Hard $oldier Hard 4 weeks ago
      $PVLA nice move today. Clear sailing ahead if they want.
      👍️0
      $oldier Hard $oldier Hard 4 months ago
      $PIRS heavy volume day
      👍️0
      Monksdream Monksdream 6 months ago
      PIRS under $20
      👍️0
      $oldier Hard $oldier Hard 8 months ago
      $PIRS low O/S merger. Held on to a few of these just for giggles.
      👍️0
      Monksdream Monksdream 8 months ago
      PIRS under $10
      👍️0
      Renee Renee 11 months ago
      PIRS: Effective April 23,2024 a one for 80 reverse split:

      https://hedgefollow.com/upcoming-stock-splits.php
      👍️0
      $oldier Hard $oldier Hard 12 months ago
      Mine went off at .265. Back on watch again.
      👍️0
      Monksdream Monksdream 12 months ago
      Wash trade in progress
      👍️0
      $oldier Hard $oldier Hard 12 months ago
      $PIRS no resistance up to .27 imo and a large gap above that.
      👍️0
      glenn1919 glenn1919 1 year ago
      PIRS...................................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
      👍️0
      Sjam410 Sjam410 1 year ago
      Big sale PM
      👍️0
      Sjam410 Sjam410 1 year ago
      Someone picked up a nice size at the close
      👍️0
      Sjam410 Sjam410 1 year ago
      Agreed. Picked up more shares today
      👍️0
      Klinsmann Klinsmann 1 year ago
      Jep, nice consolidation and may explode again on further updates
      👍️0
      Sjam410 Sjam410 1 year ago
      Anyone still watching this?
      👍️0
      Klinsmann Klinsmann 2 years ago
      There was one in the high 0.30´s, looks like it gets successfully taken down, but still could get rejected to 0.33 again. Gap in the high 0.70´s, and am not a pumper to talk about even more... I like this stock most because it takes every single step up perfectly and draws a perfect chart!
      👍️0
      Nextbigone Nextbigone 2 years ago
      What resistance levels $1-1.20?
      👍️0
      Klinsmann Klinsmann 2 years ago
      Break that resistance and we gonna have the best play of the month…
      👍️0
      Klinsmann Klinsmann 2 years ago
      Hope some of you loaded with me under 0.25. It’s go time, support at the 50ma, maybe it’s possible to go for the 0.40 break this week…
      👍️0
      Klinsmann Klinsmann 2 years ago
      Break these 0.40‘s to the 0.78 gap. On the expected updates everything possible…
      👍️0
      glenn1919 glenn1919 2 years ago
      PIRS....................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
      👍️0
      ANTI-BAGHOLDER ANTI-BAGHOLDER 2 years ago
      Interesting news. https://www.otcmarkets.com/stock/PIRS/news/story?e&id=2608442
      👍️0
      Klinsmann Klinsmann 2 years ago
      Time for the final loading before the big bang...
      👍️0
      Klinsmann Klinsmann 2 years ago
      They got a patent renewed - but still no real PR on it while similar stocks moved 100%+ on it. Still holding…
      👍️0
      budapestjs budapestjs 2 years ago
      Hey, are you able to share what the patent news is that you mentioned?
      👍️0
      Klinsmann Klinsmann 2 years ago
      Golden opp.here - patent news and still under radar
      👍️0
      glenn1919 glenn1919 2 years ago
      PIRS.........................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
      👍️0
      Triple nickle Triple nickle 2 years ago
      .22 settle
      👍️0
      $oldier Hard $oldier Hard 2 years ago
      $PIRS nice 70% pop!
      👍️0
      Triple nickle Triple nickle 2 years ago
      Off .25
      👍️0
      glenn1919 glenn1919 2 years ago
      PIRS.....................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 2 years ago
      PIRS......................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      PIRS .20 https://finance.yahoo.com/news/were-little-worried-pieris-pharmaceuticals-142856056.html
      👍️0
      willlbone willlbone 2 years ago
      Bid mid teens.
      👍️0
      $oldier Hard $oldier Hard 2 years ago
      I see that now. Quite a beating still taking. Gonna watch it to find a bottom and maybe purchase a few back.
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      PIRS .25 -71%
      👍️0
      $oldier Hard $oldier Hard 2 years ago
      $PIRS doing well now but a volatile day or sure.
      👍️0
      budapestjs budapestjs 2 years ago
      Pfizer buying out our partner Seagen
      👍️0
      $oldier Hard $oldier Hard 2 years ago
      $PIRS breaking above the 200. Might pull back some.
      👍️0
      $oldier Hard $oldier Hard 2 years ago
      $PIRS doin awesome! Keep it up.
      👍️0
      $oldier Hard $oldier Hard 2 years ago
      $PIRS back in at $1.00
      👍️0
      $oldier Hard $oldier Hard 3 years ago
      I'm having trouble now too. It popped up on Ameritrade think or swim platform.
      👍️0
      budapestjs budapestjs 3 years ago
      Hey, do you have a link for the patent news? I'm having trouble finding it. Thanks a lot.
      👍️0
      $oldier Hard $oldier Hard 3 years ago
      $PIRS good patent news just popped.
      👍️0
      NoobyDoo NoobyDoo 3 years ago
      picked up a few hundred shares today, figured it to be on sale will watch and add as needed.
      👍️0
      $oldier Hard $oldier Hard 3 years ago
      $PIRS nice move today.
      👍️0
      $oldier Hard $oldier Hard 3 years ago
      Rollin
      👍️0
      NoobyDoo NoobyDoo 3 years ago
      What a nice buying opportunity today is, and maybe just a couple more days to load up before the next run! See if it bottoms around the 200 dma - watching closely...
      👍️0

      Your Recent History

      NASDAQ
      PVLA
      Palvella Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads